FMC shares climb to three month high as Q1 results exceed estimates

Fresenius SE & Co. KGaA

06/05/2025 08:53

** Shares in Fresenius Medical Care FMEG.DE rise 4.26% after the German kidney dialysis company reported Q1 results above expectations

** FMC delivered organic revenue growth across all segments, with cost savings driving the EBIT growth, analysts at J.P.Morgan say

** Deutsche Bank says that overall, it was a solid operational release, "even though the U.S. same-market treatment growth was disappointing (but this was expected)"

** U.S. same-market treatment growth was flat in Q1, the company said in its quarterly report

** "Focus will now shift to the Capital Markets Day on 17 June where investors are anticipating an update for mid-term margins/further cost savings," JPM says

** The stock is at its highest since February

 (Reporting by Bernadette Hogg)

 ((bernadette.hogg@thomsonreuters.com))